metastatic pancreatic cancer market

Feb 02, 2021

Horizon Therapeutics Bolsters its Rare Disease Portfolio in a $3B Viela Bio Buyout Horizon Therapeutics has announced to acquire Viela Bio for about $3.1 billion to augment its portfolio and pipeline of treatments for rare diseases. The shares of Viela Bio skyrocketed more than 52% in premarket trading after the...

Nov 08, 2019

Pancreas is a gland which has two components exocrine component and endocrine component.  The exocrine component which is responsible for making proteins/ enzymes and releasing them into small intestines for easy digestion. On the other hand, the endocrine component of the pancreas is responsible for making ho...